46. What are the main risks of rejuvenation therapies?

The risks are loss of cellular identity, ectopic differentiation, tumorigenesis, fibrosis, and immune dysregulation (including autoimmunity and impaired surveillance). Mitigation strategies may include transient or partial interventions, tissue targeting, careful dosing schedules, and longitudinal monitoring with both molecular and functional readouts to detect early drift toward adverse states.